Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication
Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication
Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
NEGATIVE
Published
03 May 2026
📎 Sources
Reuters | https://www.tradingview.com/news/reuters.com,2026:newsml_FWN40505U:0-astrazeneca-pharma-india-receives-permission-to-import-durvalumab-imfinzi-for-additional-indication/